For example, the overexpression of SLC7A11 in certain cancers can be targeted by sulfasalazine to induce ferroptosis [313], whereas lapatinib, despite its ferroptotic induction capability, does not directly target SLC7A11, potentially limiting its effectiveness [314]. This evidence concerns the gene SLC7A11 and cancer.